PureHoney Technologies Partners with Cosmo Bio to Offer RapidFire-MS and Affinity Selection-MS Services in Japan
Partnership aims to provide access to PHT assay development and analytical services for Japanese clients.
BILLERICA, MA and TOKYO, JAPAN, (April 24, 2018). PureHoney Technologies and Cosmo Bio Company have announced a partnership that aims to facilitate access to PHT assay development and analytical services on the RapidFire-MS and Affinity Selection-MS platforms for Japanese clients. The PHT team has decades of experience on the RapidFire platform and has worked closely with clients ranging from top pharmaceutical companies to small biotechs on hundreds of projects and assays. Cosmo Bio is a leading biotechnology company headquartered in Tokyo, Japan and offers a wide range of reagents, kits, instrumentation to Japanese and international clients. The two companies will work together to provide PHT CRO services including both the development of novel assays for clients who already have access to their own RapidFire-MS systems as well as complete analytical solutions where samples for Japanese clients will be run in PHT laboratory in Billerica, MA. “We are excited to expand our business into Japan where there is a large number of RapidFire systems already installed in numerous drug discovery organizations,” said Can Özbal, PureHoney Technologies President and CEO, “We hope to be able to assist these clients with the development of new assays and analytical techniques to help enable new targets and therapeutic areas to be explored.” PHT has been working with clients in North America since the launch of operations in January 2015 and clients in Europe since 2017. For information call (978) 461-4760 or log onto www.purehoneytech.com.